Frexalimab (SAR441344) is a second-generation monoclonal antibody designed to target the CD40 ligand (CD40L). This antibody demonstrates a favorable safety profile and functions by inhibiting the interaction between CD40 and CD40L, thereby modulating the immune response. Frexalimab shows potential in preventing ??-cell destruction, suggesting its utility in therapeutic research related to autoimmune diseases such as multiple sclerosis, lupus erythematosus, Sj??gren?€?s syndrome, and type I diabetes.
Frexalimab (SAR441344) is a second-generation monoclonal antibody designed to target the CD40 ligand (CD40L). This antibody demonstrates a favorable safety profile and functions by inhibiting the interaction between CD40 and CD40L, thereby modulating the immune response. Frexalimab shows potential in preventing ??-cell destruction, suggesting its utility in therapeutic research related to autoimmune diseases such as multiple sclerosis, lupus erythematosus, Sj??gren?€?s syndrome, and type I diabetes.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
